Primary partner in Belgian healthcare

Saffelberg Investments has a 15% equity stake in PI Pharma, the Belgian market leader in parallel imports of European medicines. PI Pharma was set up in 2006 based on a fundamental principle of the European Union: the free circulation of goods and services. It is our aim to become a privileged partner of Belgian chemists and patients.

http://www.pipharma.be/